celgene
Is Celgene the Perfect Stock?
2:00PM 4/06/2011
Company News, Technology, Economy, Investing, Health Care, Genzyme Corporation , Pfizer, Merck, Market News, Investment
With an attractive balance sheet, healthy revenue growth and a solid return on equity, biotech company Celgene looks like a promising stock buy.
Six Top Stocks to Buy for Real Revenue Growth in 2011
11:00AM 1/21/2011
Investing, Earnings, Apple, Stock Picks, Investing Basics, Caterpillar
The path to profits for most of Corporate America lately has been cutting costs rather than raising revenue. But a careful look reveals a few companies that are poised to deliver real revenue growth. We've found six with a plus: Their stocks look like bargains.
At the 52nd annual meeting of the American Society of Hematology, which wraps up Tuesday, Novartis, Celgene and Seattle Genetics revealed the latest news from their studies on blood diseases and cancers. But despite some positive results, all three had down days in the stock market.
Deutsche Bank Initiates Amgen with a Hold, Dendreon with a Buy
3:36PM 8/16/2010
Company News, Investing, Health Care, Genzyme Corporation , Bristol-Myers Squibb, Amgen, Eli Lilly
Several biotech stocks were on the move Monday after Deutsche Bank started rating them. The bank's analyst, Robyn Karnauskas, took a generally wary view on the biotech sector, putting buy ratings only on Gilead and Dendreon.
Celgene to Buy Abraxis for $2.9 Billion
7:21AM 6/30/2010
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.
Abraxis shareholders will receive $58 and 0.2617 shares of Celgene for each Abraxis share they...
Health-Care Sector Appears to Rally As Reform Chances Dim
8:15PM 1/20/2010
Health Care, Genzyme Corporation , Bristol-Myers Squibb, CIGNA Corporation, Sanofi Aventis, Merck, GlaxoSmithKline, Amgen, Eli Lilly
President Obama can't be pleased by the loss of a Democratic Senate seat which jeopardizes passage of his cherished health-care reform. The news, however, appears to have fueled a mini stock rally in the health-care and pharma sectors wary of how any reform would affect their businesses. The uptrend is expected to continue.
S&P's Top Biotech Beneficiaries of Health Care Reform
12:00PM 12/27/2009
If the health care bills in Congress become law, the biotech sector may become one of the biggest beneficiaries. Here are six stocks and mutual funds that stand to gain the most from the changes.
Drug maker Celgene (CELG) says its multiple myeloma cancer pill reduced the risk of progression by half among newly diagnosed patients who used the drug and chemotherapy compared with those who only used chemotherapy.
Sales of Celgene's multiple myeloma drug could triple if use broadens
10:30AM 12/01/2009
There must be holiday cheer in the executive suite at biotech Celgene (CELG), where the stock is up 15% over last year. The Summit, N.J.-based company's cancer pill Revlimid generated $1.3 billion in sales last year. And it did so as a backup therapy for patients with the blood cancer multiple...
More Stories
Market Movers
| Symbol | Last | Change / % | Volume |
|---|
Most Actives
| 8.09 | -0.10 -1.16% | 144.54M | |
| 2.19 | +0.25 +12.63% | 92.86M | |
| 29.64 | -2.35 -7.35% | 23.01M | |
| 18.82 | -0.32 -1.65% | 22.24M |
% Gainers
| 32.67 | +8.77 +36.69% | 11.64M | |
| 89.23 | +12.84 +16.81% | 7.21M | |
| 2.19 | +0.25 +12.63% | 92.86M | |
| 10.56 | +1.16 +12.34% | 2.63M |
% Losers
DailyFinance Wire
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
Newswire
- Bernanke: Weak housing has hurt consumer...
- Turbo-traders take Bank of America for a ride
- Greece caught between protests, austerity...
- Stocks fall sharply as Greek deal is held up
- Trade deficit widens to $48.8 billion in...
- Feds investigate door fires in 2007 Camrys,...
- NYSE Euronext profit down on blocked merger...
- Obama call for manufacturing revival a tough...
- Petrobras Shares Volatile on $225 Billion Development Plan (PBR)
- Morning Movers (CIE, ALU, LNKD, AMRS, XIDE)
- AEP Dividend Growth Still Looks Safe Ahead (AEP)
- Arch Coal Tumbles on Earnings, Forecast (ACI, ANR, PCX, BTU, CNX)
- 2011 Trade Deficit Hits 3-Year High, Over $550 Billion
- Today’s Best Market Rumors (2/10/2012) Apple iPad, Google Entertainment
- Top Analyst Upgrades & Downgrades (ALTR, AMSC, BIIB, CELG, COH, CSTR, COP, FSLR, GILD, HAIN, MA, RF, TRLG)
- Morning Wire — US Stock-Index Futures Down Sharply
Follow Us
